Delivery Order SPE2DB22D6029-SPE2DB25FLVBT
Award Date
5/15/25
Potential Completion Date
6/6/25
Potential Value
$25K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XOLAIR 150 MG/ML SYRINGEML, a prescription medication, with a ceiling value of $8,440.40 and a period of performance through June 4, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product. The contract has a firm fixed price of $3,376.16 and a performance period ending on June 5, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $5,064.24 and a performance period ending on May 29, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any subcontractors. The...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of XOLAIR 150 MG/ML SYRINGE. The contract is a firm fixed-price delivery order with a ceiling value of $5,064.24 and a period of performance through May 27, 2025. The contract is not set aside and was awarded on May 5, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,440.40, is for the supply of XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product. The contract is a firm fixed-price delivery order, with a period of performance extending through May 20, 2025. This award is not associated with a set-aside program and represents open competition. Amerisourcebergen Drug Corp is the prime...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $5,762.72, is a delivery order for the provision of XOLAIR 150 MG/ML SYRINGE medical products. The contract has a period of performance through May 22, 2025 and is a firm fixed-price arrangement. AmerisourceBergen Drug Corp is the prime contractor, and there is no set-aside designation indicated. This award is associated with a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XOLAIR 150 MG/ML syringes, with a ceiling value of $10,128.48 and a performance period through June 6, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Xolair 75 mg/0.5 ml syringes, with a total ceiling value of $8,397.20 and a period of performance through June 6, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XOLAIR 150 MG/1.2 ML POWDER VLS. The contract has a ceiling value of $3,337.00 and a period of performance through June 2, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA), a civilian agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XOLAIR 150 MG/ML SYRINGEML, a pharmaceutical product. The contract has a firm fixed price, a ceiling value of $2,532.12, and a period of performance extending to June 9, 2025. This delivery order is not set aside and was awarded on May 16, 2025....